Responses
Rheumatoid arthritis
Original article
Early non-response to certolizumab pegol in rheumatoid arthritis predicts failure to achieve low disease activity at 1 year: data from a prospective observational study
Compose a Response to This Article
Other responses
No responses have been published for this article.